Titan Pharmaceuticals Inc (OTCQB:TTNP.PK)

0.763
Delayed Data
As of May 22
 -0.012 / -1.55%
Today’s Change
0.44
Today|||52-Week Range
0.87
+65.15%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2014
Quarter 3
2014
Quarter 4
2014
Quarter 1
2015
Revenue and IncomeNet Revenues911.0K911.0K912.0K911.0K
 
 
 
 
 
Depreciation And Amortization88.0K89.0K88.0K89.0K
 
 
 
 
 
 
Operating ExpensesGross Income----824.0K--
 
 
General Expenses1.4M1.6M2.1M2.4M
 
 
 
 
 
Research And Development748.0K782.0K1.6M1.4M
 
 
 
 
 
Total Operating Expenses1.5M1.6M2.2M2.5M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-550.0K-738.0K-1.3M-1.6M
 
 
 
 
 
Extraordinary Credit0.001.5M770.0K0.00
 
 
 
Extraordinary Charge-284.0K0.000.00-3.3M
 
 
 
Other Expenses-8.0K-7.0K10.0K-3.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-842.0K716.0K-473.0K-4.9M
 
 
 
 
 
Net Income-842.0K716.0K-473.0K-4.9M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS89.0M89.0M108.2M110.2M
 
 
 
 
 
Shares To Calculate EPS Diluted89.0M89.4M108.4M110.3M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.01-$0.01-$0.01-$0.04
 
 
 
 
 
EPS Diluted-$0.01-$0.01-$0.01-$0.04
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account